TUESDAY, Jan. 10, 2023 (HealthDay News) — Two companies are issuing new recalls on Monday for millions of previously recalled rocking sleepers for infants, with about 115 infant deaths possibly linked to use of the sleepers so far reported. With both products, the Fisher-Price Rock ‘n Play Sleepers and theContinue Reading

MONDAY, Jan. 9, 2023 (HealthDay News) — Following the deaths of 15 infants, families are advised to immediately stop using all models of Kids2 Rocking Sleepers, according to a second recall notice. Four of those 15 babies died after the first recall notice, the U.S. Consumer Product Safety Commission (CPSC)Continue Reading

FRIDAY, Jan. 6, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Friday approved a second Alzheimer’s drug, lecanemab, despite reports of rare brain bleeds linked to use of the drug in some patients. However, the FDA pointed to the drug’s benefits, as well. “Alzheimer’s disease immeasurably incapacitatesContinue Reading

THURSDAY, Jan. 5, 2023 (HealthDay News) — Lecanemab: It’s an experimental medication that’s been shown in trials to slow cognitive decline in people with Alzheimer’s disease. It’s also up for accelerated approval by the U.S. Food and Drug Administration, with a decision expected by Jan. 6. However, the drug hasContinue Reading

WEDNESDAY, Jan. 4, 2023 (HealthDay News) — Damar Hamlin, the Buffalo Bills player who collapsed Monday after suffering cardiac arrest during a game, is showing “signs of improvement,” his team said Wednesday. Still, the 24-year-old “is expected to remain under intensive care as his health care team continues to monitorContinue Reading

WEDNESDAY, Jan. 4, 2023 (HealthDay News) — Millions of Americans are about to lose Medicaid coverage that they gained — and maintained hassle-free — through the pandemic. The end-of-year spending bill that Congress passed will “unwind” a continuous Medicaid enrollment requirement that states had to honor to get additional federalContinue Reading